Strategic realignments, innovation-driven investments, and other transformative events shaped the orthopedic market in 2025.
FDA is removing barriers to real-world evidence in device applications, allowing the use of de-identified patient data from ...
CMR Surgical said it is on track to begin commercialization of its Versius Plus surgical robotic platform in 2026 in the ...